Company Profile
Incannex Healthcare Stock Price, News & Analysis
- Ticker:
- IXHL
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Australia and listed in the U
Stock performance
3.11 USD (+0.97%)
Close
Last updated: August 6, 2026
36.5M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, IXHL closed up 0.97% at $3.11. No new same-company headline was identified in the current news window.
Company overview
Business overview
Incannex Healthcare is a biotechnology company focused on cannabinoid-based and related therapies for inflammatory and sleep disorders. Its story is centered on translating cannabinoid science into specialty treatments.
Geographic Base and Sector Classification
Incannex is headquartered in Australia and listed in the U.S. market. It sits in specialty biotechnology with a cannabinoid and inflammation focus.
Business Model Characteristics
The company depends on clinical data, regulatory progress, and capital efficiency while it develops a narrow pipeline. Investors watch early signals and commercialization potential.
Position Within the Biotechnology Landscape
Incannex occupies a niche cannabinoid-biotech position. The stock is catalyst-sensitive because the company still needs to prove its therapeutic thesis in the clinic.
Future catalysts
Incannex’s catalysts are its cannabinoid / inflammatory-disease programs and any clinical step that keeps the platform alive. The stock remains highly event-driven.
Recent news
- 01
Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea
Source: Incannex Healthcare
- 02
Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea
Source: Incannex Healthcare
- 03
- 04
Incannex Announces Initiation of Research Coverage by Alliance Global Partners
Source: Incannex Healthcare
- 05
Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea
Source: Incannex Healthcare
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Incannex Healthcare (IXHL)?
Incannex Healthcare (IXHL) most recently closed at 3.11 USD, a +0.97% move versus the previous session.
What is the market cap of Incannex Healthcare (IXHL)?
Incannex Healthcare currently has a market capitalization of 36.5M USD on BioPharmSignal.
What does Incannex Healthcare do?
Incannex Healthcare is a biotechnology company focused on cannabinoid-based and related therapies for inflammatory and sleep disorders. Its story is centered on translating cannabinoid science into specialty treatments.
On which exchange is IXHL stock listed?
Incannex Healthcare (IXHL) is associated with NASDAQ, Australia and listed in the U, Biopharma.
What is Incannex?
Incannex’s catalysts are its cannabinoid / inflammatory-disease programs and any clinical step that keeps the platform alive.
Which conditions is Incannex Healthcare targeting with Incannex?
Incannex’s catalysts are its cannabinoid / inflammatory-disease programs and any clinical step that keeps the platform alive.
How does Incannex Healthcare describe recent progress with Incannex?
Incannex’s catalysts are its cannabinoid / inflammatory-disease programs and any clinical step that keeps the platform alive.
What is Healthcare?
Incannex Healthcare is a biotechnology company focused on cannabinoid-based and related therapies for inflammatory and sleep disorders.